Diabetes, Heart and Cardiovascular Diseases News Chronicle.  Diabetes, Cardiovascular and Heart Diseases
 Article 298
    Published on January 25, 2018

A new vaccine which targets enteroviruses could prevent type 1 diabetes

A study done by researchers at the Karolinska Institutet (Sweden) and the University of Tampere (Finland) shows prevention of type 1 diabetes (T1D) development by targeting enteroviruses with a newly developed prototype vaccine. Researchers claim viruses such as enteroviruses, mumps virus, rotavirus and rubella virus are causing the autoimmune condition and subsequently to the development of type 1 diabetes (T1D) in humans (including kids, children and teenagers).

The Scandinavian researchers have created their own vaccine for their experiments to find out the role played by the virus in the development of type 1 diabetes (T1D). Their experiments with mice models show that new vaccine can protect and prevent type 1 diabetes (T1D) development due to the virus without any severe adverse effects. They also found the new vaccine can protect other signs of type 1 diabetes (T1D) such as damage to the pancreas. Now they are developing a vaccine at the University of Tampere to target more viruses causing infection and leading to type 1 diabetes condition (T1D). They are going to conduct further trials before starting human clinical trials.

Type 1 diabetes prevention among children kids with an enteroviruses vaccine developed by researchers.

The study findings were published November 20, 2017, in the journal Diabetologia. Title of the article was "A Coxsackievirus B vaccine protects against virus-induced diabetes in an experimental mouse model of type 1 diabetes." Doi : dx.doi.org/10.1007/s00125-017-4492-z

If you like this article, please share it with a friend! Article address is (copy and paste the code below) :

Articles similar to this topic

1. Study Of Autoantibody Status Change
2. BCG vaccine could restore proper immune response in type 1 diabetes
3. Transplanting Bone Marrow To Cure Autoimmune Diseases
4. ViaCyte conducts embryonic stem cell implant trials in high risk type 1 diabetes patients
5. Autoimmune Diseases Decreases With Physical Exercise
6. Higher risk to the development type 1 diabetes (T1D) in early term or early birth babies
7. Enhanced risk for celiac disease in type 1 diabetes children
8. Better HbA1c A1C or glycemic control without hypoglycemic events with Dapagliflozin (Forxiga) drug in type 1 diabetic patients
9. Insulin pills may delay onset of type 1 diabetes in some individuals
10. Intestinal virus could affect type 1 diabetes development in children
11. Early β-lactam or macrolide antibiotics use was not linked with celiac disease or type 1 diabetes
12. MonoPepT1De trial shows slow down in the development of type 1 diabetes with a retrained immune system
13. Risk With Enteroviruses In Children
14. Risks With Childhood Type 1 Diabetes


Enterovirus : These are a group of viruses and live in our gastrointestinal tract. Most of the enteroviruses do not cause diseases in our gastrointestinal tract. Enteroviruses more likely to cause infections in infants and children because their immune system was not developed fully. Adult individuals infected with enteroviruses may likely show mild symptoms or no symptoms. These viruses cause common infections. Symptoms of infections caused due to enterovirus are.

  • A painful, harsh or dry sensation in the throat
  • Sneezing
  • Cough
  • Runny nose
  • Body and muscle pains
  • Sore throat
  • Vomiting
  • Fever
  • Skin affected with non-itchy rashes
  • Pink eye or conjunctivitis (or Madras eye)
  • Sores in the mouth
  • Breathing problems

Poliovirus is a group of enterovirus and causes poliomyelitis (polio or infantile paralysis). It is highly contagious and dangerous disease. These viruses will be transmitted by close contact from a infected person to another person.



Site maps

Site map 1   Site map 2   Site map 3   Site map 4

The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. Published article is not a medical advice by the OWNER of "Diabetes News Chronicle" website or by the AUTHOR of the article.

Published by Jammi Vasista, Chennai, India.
Email Jammi[no-space]Vasista1991[at]gmail[dot]com
Phone 91-944-578-3182.
Address Diabetes News Chronicle, No 40, Kaveri Street, Rajaji Nagar, Villivakkam, Chennai, India. Pin : 600049.